Hospital & Healthcare Management March 9, 2024
In a recent move, the US President Joe Biden happens to be taking on a bipartisan bogeyman prior to the crucial State of the Union speech, stressing the pharmaceutical industry as well as saying that he will work towards expanding the government’s power to lower drug prices.
In a fact sheet that has been released on March 6, the White House remarked that Medicare should be allowed in order to negotiate prices for 50 medications per year. That would be a prominent jump from the limit of 20 within the Inflation Reduction Act- IRA.
It is well to be noted that President Biden is also looking forward to expanding a $2,000 cap on out-of-pocket drug expenses towards private insurers, thereby...
Today's Sponsors
Today's Sponsor